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Celiac disease (CeD) is an immune-mediated disorder triggered by exposure to dietary
gluten proteins in genetically predisposed individuals. In addition to the host genome,
the microbiome has recently been linked to CeD risk and pathogenesis. To progress
in our understanding of the role of breast milk microbiota profiles in CeD, we have
analyzed samples from a sub-set of mothers (n = 49) included in the PreventCD project,
whose children did or did not develop CeD. The results of the microbiota data analysis
indicated that neither the BMI, HLA-DQ genotype, the CeD condition nor the gluten-free
diet of the mothers could explain the human milk microbiota profiles. Nevertheless, we
found that origin country, the offspring’s birth date and, consequently, the milk sampling
date influenced the abundance and prevalence of microbes in human milk, undergoing
a transition from an anaerobic to a more aerobic microbiota, including potential
pathogenic species. Furthermore, certain microbial species were more abundant in
milk samples from mothers whose children went on to develop CeD compared to
those that remained healthy. These included increases in facultative methylotrophs such
as Methylobacterium komagatae and Methylocapsa palsarum as well as in species
such as Bacteroides vulgatus, that consumes fucosylated-oligosaccharides present
in human milk, and other breast-abscess associated species. Theoretically, these
microbiota components could be vertically transmitted from mothers-to-infants during
breastfeeding, thereby influencing CeD risk.
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INTRODUCTION
Celiac disease (CeD) is an immune-mediated disorder triggered
by gliadin proteins and related prolamines (defined as
gluten) in genetically susceptible individuals. The disease is
characterized by a variable combination of gluten-dependent
clinical manifestations, CeD-specific antibodies, HLA-DQ2 or
HLA-DQ8 haplotypes and enteropathy (Husby et al., 2012).
The HLA-DQ2/8 genes predisposing to CeD and exposure to
gluten are necessary but not sufficient to explain CeD onset.
Emerging evidence suggests a role for the gut microbiota in
CeD risk and pathogenesis (Galipeau et al., 2015; Sanz, 2015;
Olivares et al., 2018a,b). The HLA-DQ2/8 genotype is associated
with alterations in the early colonization pattern of infants at
family risk of developing CeD (Palma et al., 2012; Olivares et al.,
2015b). Early feeding patterns, including the type of milk-feeding
(breastfeeding or formula) and the introduction of gluten into
the infant’s diet are considered determinants of CeD onset
(Silano et al., 2016). Both milk-feeding practices, particularly
breastfeeding (Palma et al., 2012), and the amount of gluten in the
diet (Sanz, 2010; Hansen et al., 2018) influence the gut microbiota
composition and could, thus, act as moderators of CeD risk. Yet,
little is known about how the host’s genetics and the environment
interact with the gut microbiota, possibly contributing to the
chain of causative mechanisms leading to CeD.
The first retrospective observational studies, which included
control individuals from a general population, found a preventive
effect of breastfeeding against later CeD development,
particularly when breastfeeding was maintained parallel to
introducing gluten into the infant diet (Auricchio et al., 1983;
Stevens et al., 1987; Greco et al., 1988). Since then, several
prospective and interventional studies including children with
genetic risk predisposing to CeD or diabetes mellitus type I,
have also tested this hypothesis but conclude that breastfeeding
and its duration do not influence CeD risk (Szajewska et al.,
2015; Silano et al., 2016). Some prospective studies report
there is no association between CeD risk and gastrointestinal
infections (Szajewska et al., 2015; Ziberna et al., 2016), however,
our prospective gut microbiota analysis found an increased
prevalence of pathogenic bacteria (enterotoxigenic Escherichia
coli) in the feces of children with increased risk of developing
CeD (Olivares et al., 2018a). Furthermore, findings from
the prospective study TEDDY indicate that gastrointestinal
infections increase the risk of CeD autoimmunity, and that
the risk depends on other factors such as breastfeeding, the
HLA genotype, infant gluten consumption, and rotavirus
vaccination (Kemppainen et al., 2017). Therefore, the
fact that previous prospective studies failed to control all
interacting elements may well explain the inconsistency
regarding the role of environmental variables like breastfeeding,
which influence both gut microbiota and oral tolerance to
allergens/gluten, in CeD onset.
A few studies have also suggested that breast-milk
composition differs depending on the mother’s health
status, which may influence its potential protective effect
in CeD and partially explain the discrepant findings across
studies. In particular, breast milk from control mothers
and mothers with CeD was found to differ in microbiota
composition (bifidobacteria) and immune mediators [secretory
immunoglobulin A (sIgA) and transforming growth factor
(TGFβ1)] and total IgA, which could be involved in the
development of oral tolerance to gluten (Olivares et al., 2015a;
Roca et al., 2018). However, this hypothesis has not been
directly proven so far. Moreover, differences in mothers’ milk
microbiota according to their CeD condition could lead to
differences in the bacteria transmitted through breastfeeding and
colonizing the infants’ gut, which could theoretically affect early
immune development and disease risk (Olivares et al., 2015a;
Demmelmair et al., 2020).
To progress in our understanding, the present pilot study
aims to investigate the relationship between mother’s breast
milk microbiota profiles and CeD development in their
offspring, including the analysis of potential covariates. A strict
methodology was applied to control for cross-contamination and
accurately identify human-milk associated bacteria.
MATERIALS AND METHODS
Study Participants and Sample
Collection
The PreventCD cohort consists of 944 children with at least
one first-degree relative with CeD and available genotype
HLA-DQ2 or HLA-DQ8 enrolled at birth, between 2007 and
2010, in Croatia, Germany, Hungary, Israel, Italy, Netherlands,
Poland, and Spain. The PreventCD project (prevention of celiac
disease1) investigates the influence of genetic, immunologic
and environmental factors on the risk of developing CeD.
All the children were assessed regularly from birth onward
for CeD development (monthly until the age of 1 year,
bimonthly until the age of 2 years, and trimonthly onward).
We periodically monitored parent-reported health status,
anthropometrics, gluten consumption and specific CeD serology
[IgA against tissue-transglutaminase (TGA)] as previously
reported (Vriezinga et al., 2014). The parents of children with
elevated TGA and/or CeD-associated symptoms suggestive of
CeD, were offered small bowel biopsies to confirm the diagnosis
or were diagnosed without biopsies according to the criteria of
the European Society for Paediatric Gastroenterology Hepatology
and Nutrition (ESPGHAN) (Husby et al., 2012). The disease
onset in children of mothers providing CeD milk samples was
diagnosed at 41.2 ± 6.38 months after birth (95% CI 34.8–47.6).
Maternal milk samples were collected at 9 months after birth.
Mothers expressed their milk manually or with a pump, but the
preferred way for the collection was not recorded. No further
specifications pre- or post-milk sampling or time of day were
given to the mothers. The milk samples were frozen at −20◦C
at home, transferred to the hospital on ice to avoid thawing and
stored at −80◦C until processed for microbiota analyses. A total
of 49 breast-milk samples from the mothers of the Dutch, Polish,
Spanish, Hungarian, and German participants in PreventCD
stored at the Leiden University Medical Center were used in
1www.preventcd.com
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this assessment. They corresponded to milk from mothers of 25
children who developed CeD and from mothers of 24 children
who did not develop CeD, referred to as “controls.” The study
was registered at ISRCTN (ISRCTN74582487) on February 26th,
2007. The first and last children were included between 26th of
May 2007 and the 25th of September 2010, respectively. This
study was conducted according to the guidelines laid down in the
Declaration of Helsinki and it was approved by all medical ethics
committees of the participating centers.
DNA Isolation and Processing
Approximately 9 mL of milk sample was combined with 1 mL
sterile 10× PBS + 0.1% Tween 20 (v/v) and mixed gently.
The samples were then filtered through 5.0 µm membranes
(Millipore) to eliminate eukaryotic cells and the flow-through
was recovered for further processing. Filtered samples were
centrifuged at 10,000 g for 10 min and pellets were stored in
1.5 mL nuclease-free tubes until processing for DNA extraction.
Cell pellets were used for DNA isolation using the PowerFecal R©
DNA Isolation Kit (Mo Bio Laboratories) following manufacturer
instructions and with a prior lysis treatment to improve DNA
extraction from resistant species. Thus, pellets were resuspended
in 300 µL sterile PBS, containing 20 U mutanolysin (Sigma) and
250 µg lysozyme (Sigma) and incubated during 60 min at 37◦C.
Given the potentially low bacterial load present in human milk
samples, we included three negative controls corresponding to
the different DNA extraction batches. These controls included a
1 mL aliquot of the 10× PBS + 0.1% Tween 20 buffer used to
homogenized milk samples prior filtration and DNA extraction.
These negative controls were equally processed during DNA
extraction, PCR, and amplicon sequencing. The human-milk-
derived genomic DNA was quantified by fluorescence-based
methods such as Qubit 3.0 and the Qubit dsDNA HS Assay
Kit (Thermo Fisher Scientific, Waltham, MA, United States),
and 1 µL DNA (0.5–5 ng) aliquot was used for microbiota
analysis. The V4–V5 hypervariable regions of the bacterial 16S
rRNA gene were amplified by 25-PCR cycles, including the
following stages: 95◦C for 20 s, 40◦C for 30 s, and 72◦C for
20 s. For PCR, Phusion High-Fidelity Taq Polymerase (Thermo
Fisher Scientific) and the 6-mer barcoded primers S-D-Bact-
0563-a-S-15 (AYTGGGYDTAAAGNG) and S-D-Bact-0907-a-A-
20 (CCGTCAATTYMTTTRAGTTT), were used to targeting the
bacterial 16S rRNA gene (Klindworth et al., 2012).
Sequencing and Data Processing
Dual barcoded PCR products, consisting of ∼400 bp, were
purified from triplicate reactions by using the Illustra GFX
PCR DNA and Gel Band Purification Kit (GE Healthcare) and
quantified through Qubit 3.0 and the Qubit dsDNA HS Assay
Kit (Thermo Fisher Scientific, Waltham, MA, United States).
Samples were multiplexed by combining equimolar quantities of
amplicon DNA (100 ng per sample) and sequenced in one lane of
Illumina MiSeq platform (Eurofins Genomics GmbH, Ebersberg,
Germany) with 2 × 300 PE configuration. The volume of purified
PCR from negative controls (with no signal of amplified DNA)
to be combined in the sequencing library was calculated as
the median of the volume used for the entire set of samples
(∼6 µL). Raw data were delivered in fastq files and paired-
ends with quality filtering were assembled using Flash software
(Magoc and Salzberg, 2011). Sample de-multiplexing was carried
out using sequence information from respective DNA barcodes
and Mothur v1.36.1 suite of analysis (Schloss et al., 2009). After
assembly and barcodes/primers removal, the sequences were
processed for chimera removal using Uchime algorithm (Edgar
et al., 2011) and SILVA reference set of 16S rRNA gene sequences
(Release 110) (Quast et al., 2013). Taxonomy assessment was
performed using the RDP classifier v2.12 (Wang et al., 2007),
using a high-quality and normalized subset of 5,000 sequences
per sample, randomly selected after shuffling (10,000×) of
the chimera removed dataset. The operational taxonomic unit
(OTU)-picking approach was performed with the normalized
subset of 5,000 sequences and the uclust algorithm (97% sequence
identity) implemented in USEARCH v8.0.1623 (Edgar, 2010)
discarding singletons and doubletons during the OTU clustering.
Non-parametric linear discriminant analysis (LDA) among cases
and controls was performed to measure differences among
human milk microbial communities at different taxonomy level
(Segata et al., 2011). Taxonomy identity of OTUs with differential
abundance was assessed using a Blast-based approach and the
NCBI non-redundant 16S rRNA gene database as well as the
SINA aligner and SILVA database annotation (Pruesse et al.,
2012). Common descriptors of the alpha diversity such as Chao’s
index, observed OTUs, Shannon index, reciprocal Simpson’s
index, dominance index, and phylogenetic distance were assessed
using the OTU level information and the qiime v1.9.1 suite of
analysis (Caporaso et al., 2010).
Potential Reagent Contaminants
Identification and Removal
Given the very low bacterial load present in human milk,
data analysis could be biased by the presence of foreign DNA
coming from DNA extraction reagents, PCR, and sequencing
approaches. To reduce this noise, we included negative controls
that enable tracing of the bacterial species unpredictably present
in reagents. In this way, we retrieved a few hundred DNA
reads from respective negative controls, and identified dozens of
bacterial groups present in those controls. The negative controls
exhibited quite a different microbiota profiling compared to
samples using multivariate analysis (Supplementary Figure S1).
An abundance-based estimation of likely contaminant OTUs was
performed by assessing predominant OTUs of negative control
samples (>0.1% in average). Then, those OTUs were removed
from control and cases samples if the abundance median was less
than five reads (0.1%).
Statistical Analysis
The statistical assessment of individual parameters and
comparison among groups was performed with Wilcoxon
rank-sum test or t-test (Welch’s correction) according to
Shapiro–Wilk normality test results, all the above implemented
in R v 3.52. Qiime v1.9.1 was also used to analyze the global
structure of microbial communities (beta diversity) through
2http://cran.r-project.org
Frontiers in Microbiology | www.frontiersin.org 3 June 2020 | Volume 11 | Article 1335
fmicb-11-01335 June 20, 2020 Time: 19:30 # 4
Benítez-Páez et al. Human-Milk Microbiota and Celiac Disease
weighted and unweighted unifrac metrics as well as to perform
principal coordinate analysis (PCoA) and statistical assessment
with permutation-based test (Permanova) (Caporaso et al.,
2010). Non-parametric correlations (Spearman’s rho) between
principal coordinate (PC) values and OTU abundances were
assessed and corrected for multiple comparisons, using the false
discovery rate (FDR) post hoc test. Linear mixed models (LMM)
were also used with log-transformed OTUs and clinical metadata
to determine potential covariates influencing the human milk
microbiota (hMM) by using the nlme R package. The metadata
used to establish associations with hMM profiles include both
children’s covariates (disease, gender, HLA-DQ genotype, birth
year, and birth season) and mother’s covariates (disease, HLA-DQ
genotype, birth year, maternity age, gluten-free diet, delivery
mode, BMI, origin country). CeD genetic risk based on HLA-DQ
genotyping (scale from 1 to 5) was calculated according to
Vriezinga et al. (2014) for the PreventCD cohort, the lower the
score the higher the DQ-associated genetic risk of CeD. Graphics




Summarized in Table 1 are the demographic and clinical
variables taken into account in the present study, due
to their potential relationship with CeD risk and the
microbiota. We found no significant difference in distribution
of such variables between the two groups compared
(controls and CeD cases).
Alpha and Beta Diversities
Six common ecological descriptors were employed to assess
the alpha diversity of the hMM in samples obtained from
mothers enrolled in the PreventCD project included in this
study. Globally, we found no differences in richness, entropy,
dominance, or diversity in control and CeD-positive cases
(mothers whose children later developed CeD), but we did
retrieve an augmented phylogenetic distance among OTUs
present in CeD samples (p < 0.001) (Figure 1). Regarding
beta diversity, weighted and unweighted Unifrac metrics were
calculated and a Permanova test was used to identify differences
in hMM structure as a function of the different variables
considered (see Table 1). As expected, we found that hMM
profiles were influenced primarily by mothers’ origin country
(unweighted unifrac based Permanova test = 1.53, p = 0.001,
weighted unifrac based Permanova test = 3.20, p = 0.001)
(Supplementary Figure S2A); however, we found that offspring’s
year of birth, referred to henceforth as “offspring birth year”
(unweighted unifrac based Permanova test = 1.40, p = 0.001,
weighted unifrac based Permanova test = 1.66, p = 0.069) also
resembled to shape the hMM (Supplementary Figure S2B).
No other covariates expected to theoretically affect hMM,
such as maternal BMI and delivery mode, were detected.
Applying an exploratory multivariate PCoA, we found that
distribution of the PC1 values of weighted unifrac correlates
TABLE 1 | Demographic and clinical variables of the mothers and children who







Maternity age 32.4 ± 2.9 33.5 ± 2.6 t = 1.338, p = 0.188
Offspring sex Female = 13 Female = 14 χ2 = 0.000, p = 1.000
Male = 11 Male = 11
Mother with
CeD
Yes = 14 Yes = 13 χ2 = 0.025, p = 0.874
No = 10 No = 12
Mother
following GFD
Yes = 12 Yes = 11 χ2 = 0.018, p = 0.893
No = 12 No = 14
Mother CeD
risk3
3.04 ± 1.60 2.75 ± 1.36 W = 256, p = 0.491
Offspring
CeD risk3
2.66 ± 1.24 2.44 ± 1.19 W = 271, p = 0.538
Offspring
birth year
2007 = 6 2007 = 7 χ2 = 3.173, p = 0.366
2008 = 15 2008 = 11
2009 = 3 2009 = 5
2010 = 0 2010 = 2
Delivery
mode4
Vaginal = 19 Vaginal = 18 χ2 = 2.001, p = 0.367
C-section = 0 C-section = 2
NA = 5 NA = 5
Maternal
BMI4,5
19.2 ± 1.9 19.0 ± 1.2 W = 78, p = 0.751
Origin
country
Germany = 8 Germany = 9 χ2 = 0.206, p = 0.995
Hungary = 7 Hungary = 6
Netherlands = 3 Netherlands = 3
Poland = 1 Poland = 1
Spain = 5 Spain = 6
1Continuous and discrete variables are shown as the average of the
distribution ± standard deviation (SD). 2Statistical comparison of variables between
groups was assessed according to their nature and distribution. Categorical
variables were evaluated with Chi-square test with Yates’ continuity correction,
whereas differences in continuous and discrete variables were evaluated with
t-test (Welch’s correction) and Wilcoxon rank-sum test for unpaired samples
according to the normal distribution of variables, tested with the Shapiro–Wilk
normality test ahead. 3CeD genetic risk based on HLA-DQ genotyping. Scores (DQ
risk group) were calculated according to Vriezinga et al. (2014) for the PreventCD
cohort. The lower the score the higher the DQ-associated genetic risk of CeD.
4Partial data recorded. Metadata for some samples is missing. 5Weight and
height recorded post-partum at milk sampling time. BMI, body mass index; GFD,
gluten-free diet; NA, not available metadata.
with birth year, suggesting that offspring birth year would
be a covariate of hMM, likely influencing its composition.
Additionally, we observed a gradient-like distribution of PC1
values across all samples dependent on children’s birth year
(Supplementary Figure S2B).
To discover the OTU abundance correlated with the
PC1 values of weighted unifrac metrics, the Spearman’s rho
parameter was calculated between the PC1 values and the
OTUs, and the p-values obtained were corrected by multiple
testing (FDR ≤ 0.05). As a result, we revealed eighteen OTUs
(rho ≥ 0.60, p < 0.001) positively correlated with PC1 values
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FIGURE 1 | Alpha diversity of the human milk microbiota. The observed richness (A), Chao’s index (B), Shannon’s index (C), reciprocal Simpson’s index (D),
dominance index (E), and phylogenetic distance (F) were calculated for samples and compared between the study groups (cases and controls; see legend color).
Non-parametric Wilcoxon rank-sum test (unpaired samples) was used to calculate differences among groups. The p-values resulting from the statistical assessment
are shown.
indicating that such phylotypes tended to be more abundant
in breast milk from mothers delivering their children during
2007 (with higher PC1 values) and reduced in the breast milk
of mothers delivering their offspring later on (2010). This could
also imply a reduction in the delivery of these phylotypes into the
intestine of infants during breastfeeding throughout the study.
When a Blast-based search was performed in order to unveil the
bacterial identity of such DNA sequences, we found conclusive
taxonomy identification for 13 out of 18 OTUs. In particular,
the abundance of the following species appear to be in higher
proportions in the breast-milk of mothers involved earlier in this
study: Anaerostipes hadrus (OTU41), Alistipes shahii (OTU39),
Parabacteroides golsteinii (OTU64), Prevotella copri (OTU7),
Faecalibacterium spp. (OTU91), Bacteroides uniformis (OTU27),
Bacteroides xylanisolvens (OTU2), Alistipes putredinis (OTU142),
Butyrivibrio crossotus (OTU40), Alistipes obesi (OTU10),
Parabacteroides johnsonii (OTU135), Bifidobacterium bifidum
(OTU32), and Paraprevotella clara (OTU101). Conversely,
negative correlations between PC1 values and OTU abundances
(rho ≤ 0.56, p < 0.001) of the species Bacillus wiedmannii
(OTU33), Enterococcus saigonensis (OTU197), and several
species of the Staphylococcus genus (OTU193, OTU331, OTU84,
and OTU2) were found. This indicates that the abundance of
these bacterial species increased progressively in breast milk
throughout the study.
Bacterial Taxonomic Composition of
hMM
The inventory of the bacterial phyla and families present in
breast milk samples was evaluated by assigning the respective
taxonomy categories to DNA reads with the RDP classifier
v2.12 as shown in Figure 2A. We found that Firmicutes and
Proteobacteria were the most common bacterial phyla present
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FIGURE 2 | Bacterial phyla and families distribution in human milk microbiota. (A) The phylum (top bar plot) and family (bottom bar plot) distribution in the whole set
of samples analyzed show the most predominant members present in different human milk samples. (B) Taxonomic categories with differential abundance in the
study groups (cases and controls). The distribution of DNA reads assigned to Verrucomicrobia phylum and Beijerinckiaceae family are presented in boxplots. In both
cases the abundance of reads is higher in case samples (CeD developed in the offspring) than in controls (p = 0.041 and p = 0.009, respectively).
in the entire set of samples followed by Bacteroidetes and
Actinobacteria. In terms of family distribution, we observed
that members of the Streptococcaceae and Staphylococcaceae
families were predominantly present in human milk samples.
Proteobacteria was mainly represented by members of
Methylobacteriaceae and Comamonadaceae families, whereas
Actinobacteria and Bacteroidetes were essentially represented by
Propionibacteriaceae and Bacteroidaceae families, respectively.
At first glance, there was a high inter-individual variability in
the microbial composition of the samples and no abundance
patterns could be visually associated with the human milk
control and CeD samples. Applying a LDA we found that milk of
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TABLE 2 | OTUs with differential abundance in breast milk samples from mothers
whose children later develop celiac disease (CeD) compared to those whose
children remained healthy (controls).
OTU Association1 LDA score p-Value Blast (% alignment,
% identity)2
OTU13 CeD 3.67 0.0324 Bacteroides vulgatus
(100, 99)
OTU42 CeD 2.87 0.0147 Methylobacterium
komagatae (100, 99)
OTU63 CeD 2.81 0.0394 Parabacteroides
distasonis (100, 100)
OTU54 CeD 2.70 0.0121 Methylocapsa
palsarum (100, 98)
1Association with CeD development; the breast milk samples showed increased
abundance in the taxonomic group recorded. 2Taxonomic identification based on
best hit during the alignments using the non-redundant 16S NCBI database.
mothers whose children later developed CeD contained a high
proportion of Verrucomicrobia (LDA score = 3.18, p = 0.041)
and Beijerinckiaceae species (LDA score = 3.36, p = 0.009)
(Figure 2B). We also detected some differences in the abundance
of specific OTUs in control mothers and mothers whose
infants developed CeD, being OTU13 (Bacteroides vulgatus),
OTU42 (Methylobacterium komagatae), OTU63 (Parabacteroides
distasonis), and OTU54 (Methylocapsa palsarum) (Table 2).
Associations Between the hMM and
Different Covariates
A LMM analysis was performed to evaluate the possible influence
of other clinical covariates on the hMM profiles. As previously
detected by beta diversity analysis, this additional data analysis
indicated that hMM structure was influenced only by the
mothers’ origin country and offspring birth year, explaining
approximately 52 and 11% of observed variability, respectively.
The above was inferred from the observation that 71 OTU
categories (p < 0.05), of the 247 most abundant identified
(>0.01% of abundance), appeared to be differentially distributed
across the offspring birth period between 2007 and 2010, whereas
93 OTUs appeared with differential abundance among the five
origin countries (p < 0.05). The OTU categories and their
most probable taxonomic identification with larger negative
and positive associations according to offspring birth year are
shown in Supplementary Figure S3. Of these, we highlight
Pseudomonas spp. (OTU14) and Acinetobacter spp. (OTU22)
(both from Pseudomonadales order), whose abundance increased
progressively with offspring birth year irrespective of the origin
country of samples (set as random effect on LMM). The
remaining covariates contributed to explain the hMM profile
to a lesser extent. Moreover, we identified 8 OTUs differentially
present in the two groups of mothers, i.e., those whose children
later developed CeD and those whose children remained healthy,
after adjusting for all other covariates (Table 3). When comparing
LDA and LMM data, we found four other OTUs associated
with the microbiota of mothers whose infants developed CeD
and two of them certainly correlated with specific species,
TABLE 3 | OTUs with differential abundance in breast milk samples from mothers
whose children later developed celiac disease (CeD) compared to those whose
children remained healthy (controls) according to LMM analysis.
OTU Association1 Variation2 p-Value Blast (% alignment,
% identity)3
SINA classsification4




OTU62 CeD −1.09 0.0195 (s) Peptoniphilus
timonensis (100, 99)
(g) Peptoniphilus (99.4)








OTU13 CeD −1.19 0.0320 (s) Bacteroides vulgatus
(100, 99)
(g) Bacteroides (99.7)




OTU483 CeD −0.60 0.0343 (s) Actinomyces
turicensis (100, 99)
(g) Actinomyces (99.7)




1Association with celiac disease (CeD) development; the breast milk samples
showed increased abundance in the taxonomic group recorded. 2Variation
calculated taking into account the control samples as reference and based
on normalized DNA read counts by logarithmic transformation. 3Taxonomic
identification based on best hit during the alignment using the non-redundant 16S
rRNA gene NCBI database. 4Taxonomic identification based on SINA aligner using
the SILVA reference database and sequence identity value against the last common
ancestor (lca). S, species; g, genus; f, family.
including Peptoniphilus timonensis (OTU62) and Actinomyces
turicencis (OTU483).
DISCUSSION
Many recent hMM surveys report the microbiota profiles
potentially involved in health and disease, not only of mothers but
also of their offspring (Sakwinska and Bosco, 2019). Controversy
exists on the most suitable methodology to accurately analyze the
microorganisms present in human milk since this niche has a very
low bacterial load. This makes it prone to misidentification of
microbial profiles due to cross-contaminations of samples with
foreign DNA from different processing stages and reagents used
for DNA isolation, PCR amplification and sequencing (Salter
et al., 2014). Therefore, the present study aimed to control
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contaminant DNA from reagents to minimize this source of
bias when assessing the microbial signatures of different human
milk samples (Sakwinska and Bosco, 2019), and to link specific
microbial features with the development of CeD in children.
We found that the microbiota of CeD samples was more
diverse than that of controls given the differences reflected
in the phylogenetic distance metrics. Moreover, most of the
primary variables and factors thought to modulate the hMM
(genetic risk, CeD mother condition, mothers’ gluten-free diet,
mothers’ age, delivery mode, and mothers’ BMI) exhibited no
significant impact on its structure. Conversely, and apart from
the well-known geographical influence on human microbiota
assessments (Kumar et al., 2016; Deschasaux et al., 2018; He
et al., 2018), replicated in this study, we found that hMM
was primarily influenced by offspring birth year in our study
population. As shown, human milk samples from 2007 to 2008
contained a higher abundance of strictly anaerobic and gut-
associated microbes such as Anaerostipes spp., Parabacteroides
spp., P. copri, Faecalibacterium spp., Bacteroides spp., Alistipes
spp., and Bifidobacterium spp. among others, whereas later
samples (2009–2010) were enriched in Bacillus, Enterococcus, and
Staphylococcus species. Therefore, the strictly anaerobic bacteria
found in the samples first collected seemed to be progressively
replaced by aerobic or facultative bacteria in the samples of
mothers collected afterward. This could be due to sample storage
time and freeze-thaw cycles but, in our study, the samples stored
for longer contained a higher abundance of strictly anaerobic
bacteria. Therefore, we hypothesize that this shift might be the
result of changes in lifestyle and environmental variables, which
shaped the assembly of such bacterial communities in mothers’
milk. Moreover, given that abundance of any of the OTUs
outlined above was not influenced by the mothers’ origin country,
delivery mode, mothers’ BMI or mothers’ disease condition
and gluten-free diet followed, the changes associated with the
offspring birth year retrieved from this sample cohort of multi-
national origin might be suggestive of a short-term switch of
hMM signatures across the population. The above idea would
be possible because of the lifestyles and environmental factors
in urban settlements has been already associated with worsening
human health, including human milk quality (Giles-Corti et al.,
2016; Pajewska-Szmyt et al., 2019), and theoretically these
factors could also negatively impact the breast milk microbiota.
Nonetheless, we are conscious that the inspection of a greater
sample size across a considerably longer sampling period will be
mandatory to test such a hypothesis. Alternatively, we cannot
discard that this hMM profile associated with offspring birth
year may be a direct consequence of milk expression method
for infant feeding, which has been demonstrated to induce
meaningful changes in the human milk by reducing diversity and
increasing potential pathogens (Moossavi et al., 2019). Despite
the fact that our metadata lacks direct information of the milk
expression method used, this hypothesis is plausible since there
is an increased tendency to use expressed breast milk feeding as
routine practice in developed countries, as those included in our
study (reviewed by Johns et al., 2013).
Analyses of the taxonomic features present in hMM at
the phylum and family level indicate that Streptococcaceae
and Staphylococcaceae species are predominant members of
the hMM. These data are consistent with previous inventories
of microbial species identified in human milk, where the
predominance of Proteobacteria and Firmicutes seems to be a
common feature (Biagi et al., 2017; Li et al., 2017; Murphy et al.,
2017). Moreover, presence of certain bacterial groups associated
with skin microbiota (like Propionibacteriaceae species) also
appears to be frequent in this type of sample.
We found increased abundance of B. vulgatus in breast-milk
samples of mothers whose children developed CeD. This species
is capable of efficiently fermenting fucosylated oligosaccharides
present in human milk (Marcobal et al., 2010) and, therefore,
human milk oligosaccharides could support their prevalence
in breast milk samples. Furthermore, B. vulgatus has been
previously linked to CeD as infants with a high genetic risk
showed an increased prevalence of this genus (Sanchez et al.,
2011). Moreover, P. distasonis was also present in higher
proportions in such samples. Although there are no previous
reports identifying the presence of these common human gut
microbes in breast milk, the abundance of B. vulgatus has
been associated with irritable bowel disease (IBD) severity
(Schirmer et al., 2018), and that of P. distasonis with Crohn’s
disease (Lopetuso et al., 2018). This evidence could hint
as to the potentially harmful effects of the transmission of
these bacterial species from mothers to their infants. Future
studies to unveil potential relationships between human milk
oligosaccharides and the abundance of microbial species found
in hMM associated with CeD children should be warranted.
This would provide further insights on the mother-child vertical
microbiota transmission since the abundance of some species
in fecal microbiota of breast-fed infants seem to correlate to
oligosaccharides present in human milk (Wang et al., 2015).
Consequently, precise mechanistic studies are necessary to test
such hypothetical associations.
Interestingly, we also found environmental-associated
microbes to be present in human milk, showing differential
abundance between study groups with higher abundance in
CeD samples. This included, in particular, Methylobacterium
species of the Rhizobiales order (phylum Proteobacteria),
which are commonly known as one-carbon compound reducer
microorganisms widely found in soil and plant surfaces.
Moreover, species of the Methylocapsa genera, members
of the Beijerinckiaceae family, formed part of the hMM
after minimizing the confounding effects of contaminant
DNA coming from reagents. Species belonging to the
Methylobacterium genus are prevalent in water pipes and
reservoirs (Barbeau et al., 1996; Vaz-Moreira et al., 2017) and as
contaminants of industrial milk samples (Bracke et al., 2014).
In addition, some studies also indicate that Methylobacterium
species are part of the human oral and skin microbiota (Hung
et al., 2011; Alekseyenko et al., 2013) and, therefore, their
presence in breast milk microbiota could partly be due to their
transmission via the infant’s oral cavity, an event that has been
recently hypothesized as important modulator of the hMM
(Moossavi and Azad, 2019; Moossavi et al., 2019). Interestingly,
a recent microbiota analysis of human breast tissue through 16S
rRNA gene amplicon sequencing has also reported the presence
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of Methylobacterium (among other environmental microbes
such as Ralstonia) in healthy and cancerous breast biopsies
(Costantini et al., 2018), supporting the presence of these type
of microbes in human breast-related samples. Although the
presence of such methylotrophs in hMM is corroborated by our
study, their particular role in CeD onset needs further evaluation.
In this regard, recent reports of the ability of Methylobacterium
species to utilize organic acids and ethanolamines, and to
produce central metabolic compounds should be investigated
further to understand their possible functional role in health and
disease (Yang et al., 2009).
A LMM-based analysis to control several covariates of
the microbiota enabled us to distinguish additional microbial
species potentially associated with the development of CeD
in children due to its increased abundance in the milk of
their respective mothers. As a result and, in addition to those
species described in Table 2, we found that the abundance
of P. timonensis and Actinomyces turicensis related OTUs
were increased in milk samples from mothers whose children
developed CeD. In this regard, Peptoniphilus species have been
considered as potential inducers of pro-inflammatory signals
associated with an increased risk of suffering from human
immunodeficiency virus (HIV) infection and wound severity
in skin ulcers (Liu et al., 2017; Park et al., 2019), which
could also confer higher susceptibility to other inflammatory
conditions such as CeD. Moreover, breast abscesses caused
by A. turicensis and Peptoniphilus harei also indicate these
bacterial taxa are potentially pathogenic (Le Bihan et al.,
2019). On the other hand, the LMM analysis also revealed
several species potentially associated with offspring birth year,
which could play an important role in the colonization of
the infant’s gut during breastfeeding. We found that P. copri,
a species recurrently associated with traditional lifestyle and
non-Westernized populations (Fragiadakis et al., 2019), was
more abundant in milk samples of mothers who delivered
their children in 2007, regardless their origin’s country, BMI,
and mothers’ disease status, and the abundance seemed to
decline in samples from mothers who delivered their children
in subsequent years. Interestingly, a similar pattern of evolution
has been found for the abundance of Prevotella species, which
seems to have been reduced in the human gut microbiota,
particularly as a result of the transition from traditional to
westernized lifestyles (Smits et al., 2017; Fragiadakis et al., 2019).
In turn, the abundance of potential pathogenic species such as
Acinetobacter and Pseudomonas exhibited the opposite pattern.
Interestingly, a recent study has reported that Pseudomonas
aeruginosa, an opportunistic pathogen from CeD patients, may
have proteolytic activity and could trigger a severe intestinal
inflammation synergistically with gluten in experimental CeD
models (Caminero et al., 2019). All in all, our study provides new
insights into the human milk bacterial profile and its potential
role in CeD onset in children in a prospective study for the
first time. This shows it could serve as a vehicle for vertical
transmission of protective or harmful bacteria, whose pathogenic
role should be investigated further.
Limitations of our study include the low sample size, the
sample heterogeneity (country origin) and the lack of records
of relevant clinical data recently demonstrated to impact the
hMM such as milk expression method (Moossavi et al., 2019).
Moreover, milk sampling for analysis (9 months after birth)
could have been completed at an earlier point, given that
infants’ gut microbiota modulation by breastfeeding also starts
earlier. However, this analysis could only be done at 9 months
because: earlier samples were processed for macronutrient and
endocrine profiling (Grunewald et al., 2019), all available milk
sample from mothers included in this pilot study were uniform
at this time point, and because all were still breastfeeding
their children, together with the introduction of complementary
food. Accordingly, we assumed that hMM would still act as
a modulator of the infants’ gut microbiota. In spite of the
limitations, this pilot study holds promise to identify new factors
that could affect hMM and impact on CeD onset in larger cohorts
and, thus, provide a more comprehensive understanding of
moderators and mediators of the disease etiology. Such a robust
design would also be necessary to clarify if the hMM profiles
could be informative to trace short-term lifestyles changes in
Western societies.
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FIGURE S1 | Principal Coordinate Analysis (PCoA) of samples and negative
controls. Bray–Curtis dissimilarity index and distance between samples and
negative controls was evaluated with OTU abundance information through
multidimensional analysis. Controls (turquoise filled circles), cases/celiac disease
(CeD, red filled circles), and negative controls (black filled circles) are represented
in this scatter plot, containing information of two main principal coordinates
explaining the largest variation among samples.
FIGURE S2 | Beta diversity analysis of the human milk microbiota. Multivariate
analysis (Principal Coordinate Analysis –PCoA) of OTUs associated with the origin
country (A) and offspring birth year (B). Distribution of PC1 and PC2 values as a
function of the both covariates are shown upon unweighted and weighted unifrac
metrics, respectively. Permanova test and p-values are shown accordingly. Color
legend is shown below respective scatter plots.
FIGURE S3 | OTUs most significantly associated with offspring birth year. The
OTUs showing the extreme variation between groups (p < 0.05) according to
LMM analysis were taxonomically identified using the SINA aligner (Pruesse et al.,
2012) and SILVA database (Quast et al., 2013). When taxonomic assignment at
genus level reached ≥99% sequence identity, identification at the species level
using a BlastN-based search against the NCBI 16S rRNA gene non-redundant
database (https://blast.ncbi.nlm.nih.gov/Blast.cgi) was completed. The
distribution of offspring delivery dates between 2007 and 2010 is presented in the
plot at the bottom. The OTUs negatively associated (yearly time-course decrease,
in light blue) and positively associated (yearly time-course increase, light red),
together with respective taxonomic identification are shown at the top. The
association slope is directly correlated to the inter-group differences detected by
LMM analysis and the respective p-values are shown within square brackets. The
abundance (Log) in terms of log10 normalized DNA reads counts and prevalence
(Prev) discriminated per birth year subgroups are disclosed, respectively.
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